References
- Crossfield SSR, Marzo-Ortega H, Kingsbury SR, Pujades-Rodriguez M, Conaghan PG. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open. 2021;7(3):e001888. DOI: 10.1136/rmdopen-2021-001888
- Xu H, Yu H, Liu L, Wu H, Zhang C, Cai W, et al. Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Peripheral Mononuclear Cells in Patients With Ankylosing Spondylitis. Front Immunol. 2021;12:760381. DOI: 10.3389/fimmu.2021.760381
- van der Heijde D, Braun J, Deodhar A, Baraliakos X, Landewé R, Richards HB, et al. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology. 2019;58(3):388-400. DOI: 10.1093/rheumatology/key128
- Wu J, Yan L, Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal. 2021;35(9):e23964. DOI: 10.1002/jcla.23964
- Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, et al. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Ann Rheum Dis. 2021;80(1):71-87. DOI: 10.1136/annrheumdis-2020-218398
- Lee YH. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Pharmacology. 2022;107(11-12):537-44. DOI: 10.1159/000525627
- Ding MH, Xu PG, Wang Y, Ren BD, Zhang JL. Resveratrol Attenuates Ankylosing Spondylitis in Mice by Inhibiting the TLR4/NF-κB/NLRP3 Pathway and Regulating Gut Microbiota. Immunol Invest. 2023;52(2):194-209. DOI: 10.1080/08820139.2022.2154162
- Xu WD, Liu SS, Pan HF, Ye DQ. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: a meta-analysis. Joint Bone Spine. 2012;79(6):566-9. DOI: 10.1016/j.jbspin.2012.02.012
- Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34. DOI: 10.1136/ard-2022-223296
- Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.
- Tsur AM, David P, Watad A, Nissan D, Cohen AD, Amital H. Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study. J Gen Intern Med. 2022;37(13):3283-8. DOI: 10.1007/s11606-021-07241-2
- Nancy Z, Yan L, Hui S, Paul B, Liye C. From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery. Front Immunol. 2021;12:624632. DOI: 10.3389/fimmu.2021.624632
- Li Y, Huang L, Cai Z, Deng W, Wang P, Su H, et al. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis. Stem Cells Dev. 2019;28(20):1398-412. DOI: 10.1089/scd.2019.0039
- Gupta L, Bhattacharya S, Agarwal V, Aggarwal A. Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease. Clin Rheumatol. 2016;35(12):3075-9. DOI: 10.1007/s10067-016-3448-x
- Olivera PA, Lasa JS, Bonovas S, Danese S, Peyrin-Biroulet L. Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis. Gastroenterology. 2020;158(6):1554-73.e12. DOI: 10.1053/j.gastro.2020.01.001
- Liao H, Li T, Chen C. Jams kinase-1 and 3 in ankylosingspondyliis. J Farmos Med Assoc. 2019;118(1 Pt 1):134-41. DOI: 10.1016/j. jfma.2018.02.001
- Facci L, Bolego C, Chemello C, Yasser R, Fusco M, Barbierato M, et al. 2-Pentadecyl-2-oxazoline inhibits lipopolysaccharide-induced microglia activation interfering with TLR4 signaling. Life Sci. 2023;335:122242. DOI: 10.1016/j.lfs.2023.122242
- Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-like receptor 4 (TLR4)/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility. Front Immunol. 2020;11:1455. DOI: 10.3389/fimmu.2020.01455
- McInnes IB, Szekanecz Z, McGonagle D, Maksymowych WP, Pfeil A, Lippe R, et al. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheumatology. 2022;61(5):1783-94. DOI: 10.1093/rheumatology/keab740
- Xu F, Guanghao C, Liang Y, Jun W, Wei W, Baorong H. Treg-promoted New Bone Formation Through Suppressing TH17 by Secreting Interleukin-10 in Ankylosing Spondylitis. Spine. 2019;44(23):E1349-55. DOI: 10.1097/BRS.0000000000003169
- Zeng J, Zhou R, Luo Z, Zhang N, Liu Z, Lin G. Clinical evidence of acupuncture and related therapy in patients with cancer-pain: A protocol for systematic review and meta-analysis. Medicine. 2020;99(45):e23119. DOI: 10.1097/MD.0000000000023119
- Liao HT, Tsai CY. Cytokines and regulatory T cells in ankylosing spondylitis. Bone Joint Res. 2023;12(2):133-7. DOI: 10.1302/2046-3758.122.BJR-2022-0195.R1
- Liu D, Liu B, Lin C, Gu J. Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis. Front Immunol. 2021;12:696973. DOI: 10.3389/fimmu.2021.696973
- Fattahi MJ, Ahmadi H, Jafarnezhad-Ansariha F, Mortazavi-Jahromi SS, Rehm BHA, Cuzzocrea S, et al. Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis. Biomed Pharmacother. 2018;100:495-500. DOI: 10.1016/j.biopha.2018.02.059